These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 30266099)

  • 41. Trimethylamine-N-oxide (TMAO) response to animal source foods varies among healthy young men and is influenced by their gut microbiota composition: A randomized controlled trial.
    Cho CE; Taesuwan S; Malysheva OV; Bender E; Tulchinsky NF; Yan J; Sutter JL; Caudill MA
    Mol Nutr Food Res; 2017 Jan; 61(1):. PubMed ID: 27377678
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gut microbiota and host metabolism in liver cirrhosis.
    Usami M; Miyoshi M; Yamashita H
    World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exploring the Microbiome in Heart Failure.
    Kitai T; Kirsop J; Tang WH
    Curr Heart Fail Rep; 2016 Apr; 13(2):103-9. PubMed ID: 26886380
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of predation stress and food ration on perch gut microbiota.
    Zha Y; Eiler A; Johansson F; Svanbäck R
    Microbiome; 2018 Feb; 6(1):28. PubMed ID: 29409543
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of the serum and liver proteomes in gut-microbiota-lacking mice.
    Tung YT; Chen YJ; Chuang HL; Huang WC; Lo CT; Liao CC; Huang CC
    Int J Med Sci; 2017; 14(3):257-267. PubMed ID: 28367086
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interactions between gut bacteria and bile in health and disease.
    Long SL; Gahan CGM; Joyce SA
    Mol Aspects Med; 2017 Aug; 56():54-65. PubMed ID: 28602676
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interaction between gut microbiome and cardiovascular disease.
    Peng J; Xiao X; Hu M; Zhang X
    Life Sci; 2018 Dec; 214():153-157. PubMed ID: 30385177
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Simultaneous HS-SPME GC-MS determination of short chain fatty acids, trimethylamine and trimethylamine N-oxide for gut microbiota metabolic profile.
    Fiori J; Turroni S; Candela M; Brigidi P; Gotti R
    Talanta; 2018 Nov; 189():573-578. PubMed ID: 30086962
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Microbial metaproteomics for characterizing the range of metabolic functions and activities of human gut microbiota.
    Xiong W; Abraham PE; Li Z; Pan C; Hettich RL
    Proteomics; 2015 Oct; 15(20):3424-38. PubMed ID: 25914197
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gut microbiota, diet, and obesity-related disorders-The good, the bad, and the future challenges.
    Portune KJ; Benítez-Páez A; Del Pulgar EM; Cerrudo V; Sanz Y
    Mol Nutr Food Res; 2017 Jan; 61(1):. PubMed ID: 27287778
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A review of metabolic potential of human gut microbiome in human nutrition.
    Yadav M; Verma MK; Chauhan NS
    Arch Microbiol; 2018 Mar; 200(2):203-217. PubMed ID: 29188341
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detrimental effects for colonocytes of an increased exposure to luminal hydrogen sulfide: The adaptive response.
    Beaumont M; Andriamihaja M; Lan A; Khodorova N; Audebert M; Blouin JM; Grauso M; Lancha L; Benetti PH; Benamouzig R; Tomé D; Bouillaud F; Davila AM; Blachier F
    Free Radic Biol Med; 2016 Apr; 93():155-64. PubMed ID: 26849947
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The influence of rosuvastatin on the gastrointestinal microbiota and host gene expression profiles.
    Nolan JA; Skuse P; Govindarajan K; Patterson E; Konstantinidou N; Casey PG; MacSharry J; Shanahan F; Stanton C; Hill C; Cotter PD; Joyce SA; Gahan CGM
    Am J Physiol Gastrointest Liver Physiol; 2017 May; 312(5):G488-G497. PubMed ID: 28209601
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of gut microbiota in atherosclerosis.
    Jonsson AL; Bäckhed F
    Nat Rev Cardiol; 2017 Feb; 14(2):79-87. PubMed ID: 27905479
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gut Dysbiosis in Animals Due to Environmental Chemical Exposures.
    Rosenfeld CS
    Front Cell Infect Microbiol; 2017; 7():396. PubMed ID: 28936425
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trimethylamine N-Oxide, the Microbiome, and Heart and Kidney Disease.
    Zeisel SH; Warrier M
    Annu Rev Nutr; 2017 Aug; 37():157-181. PubMed ID: 28715991
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative gut microbiota and resistome profiling of intensive care patients receiving selective digestive tract decontamination and healthy subjects.
    Buelow E; Bello González TDJ; Fuentes S; de Steenhuijsen Piters WAA; Lahti L; Bayjanov JR; Majoor EAM; Braat JC; van Mourik MSM; Oostdijk EAN; Willems RJL; Bonten MJM; van Passel MWJ; Smidt H; van Schaik W
    Microbiome; 2017 Aug; 5(1):88. PubMed ID: 28803549
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Local and Long-Distance Calling: Conversations between the Gut Microbiota and Intra- and Extra-Gastrointestinal Tract Infections.
    Denny JE; Powell WL; Schmidt NW
    Front Cell Infect Microbiol; 2016; 6():41. PubMed ID: 27148490
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Investigating a holobiont: Microbiota perturbations and transkingdom networks.
    Greer R; Dong X; Morgun A; Shulzhenko N
    Gut Microbes; 2016; 7(2):126-35. PubMed ID: 26979110
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reducing Viability Bias in Analysis of Gut Microbiota in Preterm Infants at Risk of NEC and Sepsis.
    Young GR; Smith DL; Embleton ND; Berrington JE; Schwalbe EC; Cummings SP; van der Gast CJ; Lanyon C
    Front Cell Infect Microbiol; 2017; 7():237. PubMed ID: 28634574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.